KCNQ Channels in Nociceptive Cold-Sensing Trigeminal Ganglion Neurons as Therapeutic Targets for Treating Orofacial Cold Hyperalgesia
Open Access
- 1 January 2015
- journal article
- Published by SAGE Publications in Molecular Pain
- Vol. 11, 45
Abstract
Background: Hyperexcitability of nociceptive afferent fibers is an underlying mechanism of neuropathic pain and ion channels involved in neuronal excitability are potentially therapeutic targets. KCNQ channels, a subfamily of voltage-gated K+ channels mediating M-currents, play a key role in neuronal excitability. It is unknown whether KCNQ channels are involved in the excitability of nociceptive cold-sensing trigeminal afferent fibers and if so, whether they are therapeutic targets for orofacial cold hyperalgesia, an intractable trigeminal neuropathic pain. Methods: Patch-clamp recording technique was used to study M-currents and neuronal excitability of cold-sensing trigeminal ganglion neurons. Orofacial operant behavioral assessment was performed in animals with trigeminal neuropathic pain induced by oxaliplatin or by infraorbital nerve chronic constrictive injury. Results: We showed that KCNQ channels were expressed on and mediated M-currents in rat nociceptive cold-sensing trigeminal ganglion (TG) neurons. The channels were involved in setting both resting membrane potentials and rheobase for firing action potentials in these cold-sensing TG neurons. Inhibition of KCNQ channels by linopirdine significantly decreased resting membrane potentials and the rheobase of these TG neurons. Linopirdine directly induced orofacial cold hyperalgesia when the KCNQ inhibitor was subcutaneously injected into rat orofacial regions. On the other hand, retigabine, a KCNQ channel potentiator, suppressed the excitability of nociceptive cold-sensing TG neurons. We further determined whether KCNQ channel could be a therapeutic target for orofacial cold hyperalgesia. Orofacial cold hyperalgesia was induced in rats either by the administration of oxaliplatin or by infraorbital nerve chronic constrictive injury. Using the orofacial operant test, we showed that retigabine dose-dependently alleviated orofacial cold hyperalgesia in both animal models. Conclusion: Taken together, these findings indicate that KCNQ channel plays a significant role in controlling cold sensitivity and is a therapeutic target for alleviating trigeminal neuropathic pain that manifests orofacial cold hyperalgesia.Keywords
Funding Information
- Office of Extramural Research (DE018661)
- Office of Extramural Research (DE023090)
This publication has 29 references indexed in Scilit:
- Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the ratToxicology, 2007
- Chemical and Cold Sensitivity of Two Distinct Populations of TRPM8-Expressing Somatosensory NeuronsJournal of Neurophysiology, 2006
- TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injuryJournal of Clinical Investigation, 2005
- Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivityPain, 2005
- Oxaliplatin-Associated Neuropathy: A ReviewAnnals of Pharmacotherapy, 2005
- Menthol-Induced Ca2+Release from Presynaptic Ca2+Stores Potentiates Sensory Synaptic TransmissionJournal of Neuroscience, 2004
- KCNQ/M Currents in Sensory Neurons: Significance for Pain TherapyThe Journal of Neuroscience, 2003
- A cold‐ and menthol‐activated current in rat dorsal root ganglion neurones: properties and role in cold transductionThe Journal of Physiology, 2002
- A TRP Channel that Senses Cold Stimuli and MentholCell, 2002
- Identification of a cold receptor reveals a general role for TRP channels in thermosensationNature, 2002